(Updated - October 25, 2021 4:31 AM EDT)

JPMorgan analyst Anupam Rama upgraded Vir Biotechnology (NASDAQ: VIR) from Underweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE